SCHEDULE 13G/A

Terns Pharmaceuticals Inc

Common Stock, $0.0001 par value per share · CUSIP: 880881107

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Soleus Capital Master Fund, L.P.

  Shares: 212,710.00 · Class: 0.2%

• Soleus Capital, LLC

  Shares: 212,710.00 · Class: 0.2%

• Soleus Capital Group, LLC

  Shares: 212,710.00 · Class: 0.2%

• Soleus Capital Management, L.P.

  Shares: 212,710.00 · Class: 0.2%

• Soleus GP, LLC

  Shares: 212,710.00 · Class: 0.2%

• Guy Levy

  Shares: 212,710.00 · Class: 0.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.